| Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis M Wang, AM Zukas, Y Hui, E Ricciotti, E Puré, GA FitzGerald Proceedings of the National Academy of Sciences 103 (39), 14507-14512, 2006 | 248 | 2006 |
| Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism KM Egan, M Wang, MB Lucitt, AM Zukas, E Puré, JA Lawson, ... Circulation 111 (3), 334-342, 2005 | 241 | 2005 |
| Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis PS Acharya, A Zukas, V Chandan, ALA Katzenstein, E Puré Human pathology 37 (3), 352-360, 2006 | 214 | 2006 |
| Handbook of neuro-oncology neuroimaging HB Newton Academic Press, 2016 | 96 | 2016 |
| Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease MK Middleton, AM Zukas, T Rubinstein, M Jacob, P Zhu, L Zhao, I Blair, ... The Journal of experimental medicine 203 (11), 2529-2540, 2006 | 81 | 2006 |
| CD44 expressed on both bone marrow–derived and non–bone marrow–derived cells promotes atherogenesis in ApoE-deficient mice L Zhao, E Lee, AM Zukas, MK Middleton, M Kinder, PS Acharya, JA Hall, ... Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1283-1289, 2008 | 52 | 2008 |
| Autologous stem-cell transplantation for primary central nervous system lymphoma: systematic review and meta-analysis I Alnahhas, M Jawish, M Alsawas, A Zukas, L Prokop, MH Murad, ... Clinical Lymphoma Myeloma and Leukemia 19 (3), e129-e141, 2019 | 42 | 2019 |
| CD44 regulates vascular gene expression in a proatherogenic environment L Zhao, J A. Hall, N Levenkova, E Lee, MK Middleton, AM Zukas, ... Arteriosclerosis, thrombosis, and vascular biology 27 (4), 886-892, 2007 | 39 | 2007 |
| Neurological complications of new chemotherapy agents AM Zukas, D Schiff Neuro-oncology 20 (1), 24-36, 2018 | 35 | 2018 |
| 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis MK Middleton, AM Zukas, T Rubinstein, M Kinder, EH Wilson, P Zhu, ... Infection and Immunity 77 (12), 5690-5700, 2009 | 24 | 2009 |
| Geographically remote cerebral venous sinus thrombosis in patients with intracranial tumors DMS Raper, AM Zukas, D Schiff, AR Asthagiri World Neurosurgery 98, 555-562, 2017 | 13 | 2017 |
| Autonomic instability and asystole: Broadening the differential diagnosis of cardiac arrhythmias R Chawla, AM Zukas, JH Pitcher, C Trankle, L Brath, A Abbate International Journal of Cardiology 220, 665-667, 2016 | 6 | 2016 |
| Neurological complications of systemic cancer and antineoplastic therapy HB Newton, MG Malkin Informa Healthcare, 2010 | 6 | 2010 |
| OS5. 7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma AM Zukas, N Bennani, C Chou, P Johnston, B O’Neill, M Nijland, ... Neuro-oncology, 2016 | 5 | 2016 |
| Study protocol for cognitive behavioral therapy for insomnia in patients with primary brain tumor: a single-arm phase 2a proof-of-concept trial AR Loughan, A Lanoye, KD Willis, SG Ravyts, A Fox, A Zukas, Y Kim Contemporary Clinical Trials Communications 32, 101083, 2023 | 2 | 2023 |
| OS5. 8 Intravascular lymphoma affecting the central nervous system: features and outcomes in a case series of the Primary CNS Lymphoma Collaborative Group (IPCG) AM Zukas, N Bennani, C Chou, P Johnston, B O’Neill, M Nijland, ... Neuro-Oncology 18 (suppl_4), iv13-iv13, 2016 | 2 | 2016 |
| Low-dose radiation followed by on-target inhibition of Galectin-3 in combination with anti-4-1BB monoclonal antibody regulates immune responses in Group 3 and Group 4 … D Cachia, R Eskandari, DG McDonald, LK Infinger, WA Vandergrift III, ... Neurology 100 (17_supplement_2), 3857, 2023 | 1 | 2023 |
| Cognitive Behavioral Therapy for Insomnia in Patients with Glioma A Loughan Ph. D. Thesis, 2020 | 1 | 2020 |
| RARE-39. INTRAVASCULAR LYMPHOMA AFFECTING THE CENTRAL NERVOUS SYSTEM: FEATURES AND OUTCOMES IN A CASE SERIES OF THE PRIMARY CNS LYMPHOMA COLLABORATIVE GROUP (IPCG) A Zukas, N Bennani, C Chou, P Johnston, BP O’Neill, M Nijland, ... Neuro-Oncology 18 (suppl_6), vi168-vi168, 2016 | 1 | 2016 |
| RARE-23TWO CASES OF RARE INTRASPINAL POORLY DIFFERENTIATED NEUROENDOCRINE TUMOR WITH EXCELLENT RESPONSES TO RADIATION THERAPY A Zukas, M Hays, D Schiff Neuro-Oncology 17 (Suppl 5), v205, 2015 | 1 | 2015 |
Ashlee LoughanNeuropsychologist; Associate Professor of Neurology, Virginia Commonwealth University在 vcuhealth.org 的电子邮件经过验证
Ashlee LoughanNeuropsychologist; Associate Professor of Neurology, Virginia Commonwealth University在 vcuhealth.org 的电子邮件经过验证